Stockscreener 앱 받기
1.795
0.97%
-0.0175
전일 마감가:
$1.8125
열려 있는:
$1.8355
하루 거래량:
50,221
Relative Volume:
0.37
시가총액:
$66.59M
수익:
$68.72M
순이익/손실:
$-24.01M
주가수익비율:
-2.851
EPS:
-0.6296
순현금흐름:
$-24.95M
1주 성능:
+3.13%
1개월 성능:
-19.14%
6개월 성능:
-27.18%
1년 성능:
-66.70%
1일 변동 폭
$1.78
$1.84
1주일 범위
$1.73
$1.8894
52주 변동 폭
$1.26
$5.4999
Edap Tms S A Adr Stock (EDAP) Company Profile
EDAP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EDAP
Edap Tms S A Adr
|
1.795 | 65.08M | 68.72M | -24.01M | -24.95M | -0.6296 |
|
MCK
Mckesson Corporation
|
714.88 | 90.05B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
291.55 | 56.87B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
155.48 | 36.92B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
70.57 | 9.21B | 12.50B | 314.00M | 421.00M | 2.44 |
|
YI
111 Inc Adr
|
8.08 | 69.56M | 2.05B | -45.99M | 5.54M | -0.5634 |
Edap Tms S A Adr Stock (EDAP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-15 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-04-04 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-11-01 | 개시 | Jefferies | Buy |
| 2021-04-28 | 개시 | Piper Sandler | Overweight |
| 2020-04-15 | 개시 | B. Riley FBR | Buy |
| 2014-07-28 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2014-06-16 | 개시 | H.C. Wainwright | Buy |
| 2013-03-05 | 개시 | Northland Capital | Outperform |
| 2010-11-18 | 재확인 | Morgan Joseph | Buy |
| 2009-08-20 | 재확인 | Roth Capital | Hold |
| 2008-11-24 | 재확인 | Roth Capital | Hold |
| 2008-03-26 | 재확인 | Roth Capital | Hold |
| 2007-11-09 | 재확인 | Roth Capital | Hold |
| 2007-03-16 | 재확인 | Roth Capital | Hold |
| 2007-01-24 | 재확인 | Roth Capital | Hold |
모두보기
Edap Tms S A Adr 주식(EDAP)의 최신 뉴스
edap tms sa announces shareholder meeting for june 2025 By Investing.com - Investing.com UK
H.C. Wainwright cuts EDAP stock price target to $14 By Investing.com - Investing.com South Africa
H.C. Wainwright cuts EDAP stock price target to $14 - Investing.com
EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting - GlobeNewswire Inc.
Focal ablation shows promise in prostate cancer trial - Investing.com
Jefferies cuts EDAP TMS stock rating, slashes target to $2 - Investing.com
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating By Investing.com - Investing.com South Africa
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating - Investing.com India
H.C. Wainwright maintains $19 target on EDAP TMS stock - Investing.com India
Earnings call transcript: EDAP TMS Q4 2024 sees revenue growth, stock surges - Investing.com
Allegro Microsystems Inc (ALGM) Beta Value: Understanding the Market Risk - The News Heater
EDAP TMS SA Sponsored ADR to Host Earnings Call - ACCESS Newswire
Investor Network: EDAP TMS SA Sponsored ADR to Host Earnings Call - ACCESS Newswire
EDAP initiates trial for pancreatic cancer treatment - Investing.com India
Earnings call: EDAP TMS sees growth with Focal One HIFU business - Investing.com
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap It Up Now? - Barchart
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts - Benzinga
Biotech & Pharma News, Stocks, FDA Decision, Clinical Trials - RTTNews
Perkins Capital Raises Exposure in EDAP TMS - Insider Monkey
Friday's Top Biotech and Medical Stocks - 24/7 Wall St.
Edap Tms S A Adr (EDAP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.94%
10.39%
자본화:
|
볼륨(24시간):